Efficacy and safety of cervicothoracic epidural blood patch for patients with spontaneous intracranial hypotension. Issue 6 (27th May 2022)

• Record Type: Journal Article
• Authors: Hsu, Chieh‐Min; Liu, Yu‐Cheng; Chen, Ying‐Chu; Fuh, Jong‐Ling; Huang, Hui‐Chun; Wang, Yen‐Feng; Chiang, I‐Ying; Wen, Yeong‐Ray
• Is Part Of: Pain practice. Volume 22:Issue 6(2022)
• Page Start: 586
• Page End: 591
• Publication Date: 2022-05-27
• Subjects: cerebrospinal fluid leak -- cervical epidural blood patch -- low pressure headache -- orthostatic headache -- spontaneous intracranial hypotension; Pain -- Treatment -- Periodicals; 616.0472
• DOI: 10.1111/papr.13126
• Languages: English
• ISSNs: 1530-7085

Abstract

Abstract: Background: Epidural blood patch (EBP) is a generally effective treatment for spontaneous intracranial hypotension (SIH) caused by cerebrospinal fluid (CSF) leakage through the spinal dura mater. It is still unclear; however, whether application near the leakage site (targeted EBP) is more effective than distal application (untargeted EBP). Further, EBP targeted to high thoracic or cervical spine levels is infrequent due to greater technical requirements and potential complications. Here, we examined the safety and efficacy of EBP applied to high thoracic or cervical spine levels. Methods: We retrospectively reviewed the clinical and outcome data of 13 patients receiving cervical or high thoracic EBP for SIH. All patients were referred by neurologists following poor response to conservative treatment and presented with persistent headache aggravated by orthostatic changes. Results: Neuroimaging confirmed CSF leakage and targeted EBP resulted in immediate pain improvement. Repeated injections provided additional improvement for patients with recurrent headache. No serious adverse events were documented during follow‐up. Conclusion: Based on recent studies and our clinical experience, we conclude that EBP targeted to the high thoracic and cervical spine is safe and effective for early‐stage SIH.